Exon 2 variants (rs3811046 and rs3811047) of the IL37 gene are associated with susceptibility to systemic lupus erythematosus

References

• Tian J, Zhang D, Yao X, et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82:351–356. doi: 10.1136/ard-2022-223035
   PubMed Web of Science ®Google Scholar
• Sticherling M, Kuhn A. Lupus erythematosus. Braun-Falco’s Dermatology. Berlin Heidelberg: Springer; 2022. p. 923–939. doi: 10.1007/978-3-662-63709-8_54
   Google Scholar
• Ameer MA, Chaudhry H, Mushtaq J, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022;14:e30330. doi: 10.7759/cureus.30330
   PubMed Web of Science ®Google Scholar
• Damoiseaux J, van Beers J. Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus. J Transl Autoimmun. 2023;6:100191. doi: 10.1016/j.jtauto.2023.100191
   PubMedGoogle Scholar
• Rincón-Delgado KL, Tovar-Sánchez C, Fernández-Ávila DG, et al. Role of cytokines in the pathophysiology of systemic lupus erythematosus. Rev Colomb Reumatol. 2021;28:144–155. doi: 10.1016/j.rcreu.2021.05.018
   Google Scholar
• Alduraibi FK, Sullivan KA, Chatham WW, et al. Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: a cross-sectional study. Clin Immunol. 2023;247:109239. doi: 10.1016/j.clim.2023.109239
   PubMed Web of Science ®Google Scholar
• Alduraibi FK, Tsokos GC. Lupus nephritis biomarkers: a critical review. Int J Mol Sci. 2024;25:805. doi: 10.3390/ijms25020805
   PubMed Web of Science ®Google Scholar
• Zeng H, Zhou K, Ye Z. Biology of interleukin‑37 and its role in autoimmune diseases (review). Exp Ther Med. 2022;24:495. doi: 10.3892/etm.2022.11422
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhou J, Yuan ZC, et al. Association between IL-37 and systemic lupus erythematosus risk. Immunol Invest. 2022;51:727–738. doi: 10.1080/08820139.2020.1869254
   PubMed Web of Science ®Google Scholar
• Yan X, Xie B, Wu G, et al. Interleukin-37: the effect of anti-inflammatory response in human coronary artery endothelial cells. Mediators Inflamm. 2019;2019:2650590. doi: 10.1155/2019/2650590
   PubMed Web of Science ®Google Scholar
• Su Z, Tao X. Current understanding of IL-37 in human health and disease. Front Immunol. 2021;12:696605. doi: 10.3389/fimmu.2021.696605
   PubMed Web of Science ®Google Scholar
• Wu GC, Li HM, Wang JB, et al. Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients. Lupus. 2016;25:1377–1380. doi: 10.1177/0961203316646462
   PubMed Web of Science ®Google Scholar
• Godsell J, Rudloff I, Kandane-Rathnayake R, et al. Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus. Sci Rep. 2016;6:1–10. doi: 10.1038/srep34604
   PubMed Web of Science ®Google Scholar
• Ye L, Ji L, Wen Z, et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med. 2014;12:69. doi: 10.1186/1479-5876-12-69
   PubMed Web of Science ®Google Scholar
• Ahmed AA, Ad’hiah AH. Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients. Meta Gene. 2022;31:100989. doi: 10.1016/j.mgene.2021.100989
   PubMed Web of Science ®Google Scholar
• Özgüçlü S, Duman T, Ateş FSÖ, et al. Serum interleukin-37 level and interleukin-37 gene polymorphism in patients with behçet disease. Clin Rheumatol. 2019;38:495–502. doi: 10.1007/s10067-018-4288-7
   PubMedGoogle Scholar
• Lin XY, Guo XJ, He YZ, et al. Association between interleukin 37 (rs3811047) polymorphism and multiple autoimmune diseases in a Chinese population. Med (United States). 2018;97(15):e0386. doi: 10.1097/MD.0000000000010386
   Google Scholar
• Cirelli T, Nepomuceno R, Orrico SRP, et al. Validation in a Brazilian population of gene markers of periodontitis previously investigated by GWAS and bioinformatic studies. J Periodontol. 2021;92:689–703. doi: 10.1002/JPER.20-0126
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. doi: 10.1002/art.1780400928
   PubMed Web of Science ®Google Scholar
• Koelmeyer R, Nim HT, Nikpour M, et al. High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus. Lupus Sci Med. 2020;7:e000372. doi: 10.1136/lupus-2019-000372
   PubMed Web of Science ®Google Scholar
• Siedner MJ, Gelber AC, Rovin BH, et al. Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis. J Rheumatol. 2008;35(1):84–90.
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. Shesis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–98. doi: 10.1038/sj.cr.7290272
   PubMed Web of Science ®Google Scholar
• Wautier JL, Wautier MP. Pro- and anti-inflammatory prostaglandins and cytokines in Humans: a mini review. Int J Mol Sci. 2023;24:9647. doi: 10.3390/ijms24119647
   PubMed Web of Science ®Google Scholar
• Jia H, Liu J, Han B. Reviews of interleukin-37: functions, receptors, and roles in diseases. Biomed Res Int. 2018;2018:3058640. doi: 10.1155/2018/3058640
   PubMed Web of Science ®Google Scholar
• Wang L, Quan Y, Yue Y, et al. Interleukin-37: a crucial cytokine with multiple roles in disease and potentially clinical therapy (review). Oncol Lett. 2018;15:4711. doi: 10.3892/OL.2018.7982
   PubMed Web of Science ®Google Scholar
• Song L, Qiu F, Fan Y, et al. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol. 2013;33:111–117. doi: 10.1007/s10875-012-9791-z
   PubMed Web of Science ®Google Scholar
• Lee YH, Song GG. Circulating interleukin-37 levels in Rheumatoid Arthritis and Systemic lupus erythematosus and their correlations with disease activity: a meta-analysis. J Rheum Dis. 2020;27:152–158. doi: 10.4078/jrd.2020.27.3.152
   Google Scholar
• Yan N, Meng S, Song RH, et al. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease. J Mol Endocrinol. 2015;55:209–218. doi: 10.1530/JME-15-0144
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zuo Y, Li C, et al. IL1F7 gene polymorphism is not associated with rheumatoid arthritis susceptibility in the northern Chinese han population: a case-control study. Chin Med J (Engl). 2018;131:171–179. doi: 10.4103/0366-6999.222340
   PubMed Web of Science ®Google Scholar
• Allam G, Mohamed IAA, Alswat KA, et al. Association of IL-37 gene polymorphisms with susceptibility to tuberculosis in Saudi subjects. Microbiol Immunol. 2016;60:778–786. doi: 10.1111/1348-0421.12444
   PubMed Web of Science ®Google Scholar
• Mookherjee S, Banerjee D, Chakraborty S, et al. Evaluation of the IL1 gene cluster single nucleotide polymorphisms in primary open-angle glaucoma pathogenesis. Genet Test Mol Biomarkers. 2016;20:633–636. doi: 10.1089/gtmb.2015.0344
   PubMed Web of Science ®Google Scholar
• Davarpanah E, Jafarzadeh A, Nemati M, et al. Circulating concentration of interleukin-37 in helicobacter pylori-infected patients with peptic ulcer: its association with IL-37 related gene polymorphisms and bacterial virulence factor CagA. Cytokine. 2020;126:154928. doi: 10.1016/j.cyto.2019.154928
   PubMed Web of Science ®Google Scholar
• Tan H, Deng B, Yu H, et al. Genetic analysis of innate immunity in Behcet’s disease identifies an association with IL-37 and IL-18RAP. Sci Rep. 2016;6:35802. doi: 10.1038/srep35802
   PubMed Web of Science ®Google Scholar